Bronchial Spasm Market is driven by asthma prevalence rise
Bronchial spasm therapies encompass a range of inhalers, nebulizers, bronchodilators, anticholinergics, and combination drugs designed to relax airway smooth muscles and alleviate acute respiratory distress. These products offer rapid onset of action, targeted delivery to the bronchial tree, and improved patient compliance. Bronchodilator inhalers, such as short-acting beta-agonists (SABAs) and...
0 Commentarii 0 Distribuiri 74 Views 0 previzualizare